A Study to Evaluate the Efficacy and Safety of AD-203

NCT04066530 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

475

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Gastritis
Chronic Gastritis

Interventions

DRUG: AD-203
DRUG: Mucosta tab.

Sponsor

Addpharma Inc.